Cargando…
Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
Background: The effect of clopidogrel, whose mechanism of action differs from that of aspirin, on CRC risk remains unknown. We investigated the effects of clopidogrel and aspirin, either as monotherapy or combined, on colorectal cancer (CRC) risk in patients with Type 2 diabetes mellitus (T2DM). Met...
Autores principales: | Kuan, Yi-Chun, Huang, Kuang-Wei, Lin, Cheng-Li, Luo, Jiing-Chyuan, Kao, Chia-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827090/ https://www.ncbi.nlm.nih.gov/pubmed/31569587 http://dx.doi.org/10.3390/cancers11101468 |
Ejemplares similares
-
Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019) -
Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022) -
Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004) -
Aspirin‐based chemoprevention of colorectal cancer: The role for gut microbiota
por: Diao, Feiyu, et al.
Publicado: (2020) -
Chemoprevention by aspirin against inflammation-related colorectal cancer in mice
por: Ohnishi, Shiho, et al.
Publicado: (2021)